(51) determined the expression level of SLFN5 protein in renal clear cell carcinoma using immunohistochemical techniques and found that SLFN5 expression decreased with increasing age, higher pathological grade, higher T stage, and clinical stage in RCC patients. This evidence concerns the gene SLFN5 and renal cell carcinoma.